Status:
UNKNOWN
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
Xinjiang Corps Hospital
Conditions:
Atrial Fibrillation Recurrent
Eligibility:
All Genders
18-75 years
Brief Summary
This is a prospective and observational study. The investigator speculated that the use of DC in patients with paroxysmal AF can serve as a predictor for early and late AF recurrence following CPVI.
Detailed Description
Atrial fibrillation (AF), also known as atrial flutter, is one of the most common cardiac arrhythmias and poses a serious threat to patients' health and well-being. The mechanism of AF is complex, wit...
Eligibility Criteria
Inclusion
- Sign the informed consent form;
- Clearly diagnosed as paroxysmal AF, willing to receive CPVI treatment;
- A class I or class III antiarrhythmic drug with poor efficacy, or intolerance to drugs.
Exclusion
- Diagnosis of sinus rhythm at recruitment;
- Age is \<18 years old or\> 75 years old;
- Transthoracic echocardiography suggested a left atrial anterior and posterior diameter of\> 55mm;
- Previous history of catheter ablation or surgical ablation for AF;
- Left atrial thrombus recorded by ultrasound or CT;
- With severe pulmonary diseases;
- Previous history of cardiac surgery;
- Patients with hyperthyroidism, atrial septal defect, mitral valve stenosis or severe coronary heart disease who need further treatment;
- During pregnancy or lactation.
Key Trial Info
Start Date :
September 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06202209
Start Date
September 13 2023
End Date
October 30 2024
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China